215600 — SillaJen Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for SillaJen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS/A	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,069	1,670	254	5,013	3,940
Cost of Revenue
Gross Profit	—	—	—	1,483	1,457
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	156,127	47,880	20,604	29,514	25,283
Operating Profit	-147,058	-46,210	-20,350	-24,501	-21,344
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-113,196	-47,825	-22,124	-23,901	-20,181
Provision for Income Taxes
Net Income After Taxes	-113,200	-47,825	-15,305	-24,593	-20,369
Net Income Before Extraordinary Items
Net Income	-113,200	-47,825	-15,305	-24,593	-20,369
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-113,200	-47,825	-15,305	-24,593	-20,369
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-787	-500	-181	-239	-198
Dividends per Share